Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of methods to detect p53 mutations in ovarian cancer.

Oncology - 1 Jan 2001

Meinhold-Heerlein I, Ninci E, Ikenberg H, Brandstetter T, Ihling C, Schwenk I, Straub A, Schmitt B, Bettendorf H, Iggo R, Bauknecht T

Abstract excerpt

OBJECTIVE: The p53 status is increasingly regarded as a marker predictive of response to particular cancer therapies, but for this approach it is self-evident that the p53 status must be determined correctly. METHODS: We have tested ovarian cancers with single-strand conformation polymorphism ana...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Mutational Analysis
Share to Genes, p53
Share to Immunohistochemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Polymerase Chain Reaction

Share to Polymorphism, Single-Stranded Conformational

Share to Sequence Analysis, DNA

Share to Yeasts

Source

Identifiers

PMID: 11244334
DOI: 10.1159/000055316

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11244334-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of methods to detect p53 mutations in ovarian cancer.PMID 11244334Read ↗

Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY.Semantic proximity Read ↗

The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer.Semantic proximity Read ↗

Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay.Semantic proximity Read ↗

p53 status in breast carcinomas revealed by FASAY correlates well with p53 protein accumulation determined by immunohistochemistry.Semantic proximity Read ↗

Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response.Semantic proximity Read ↗

p53 mutations and expression in ovarian cancers: correlation with overall survival.Semantic proximity Read ↗

Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation.Semantic proximity Read ↗

Correlations of breast carcinoma biomarkers and p53 tested by FASAY and immunohistochemistry.Semantic proximity Read ↗

Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single strand conformation polymorphism.Semantic proximity Read ↗

Genomic semi-automated cycle sequencing as a sensitive screening technique for p53 mutations in frozen tumor samples.Semantic proximity Read ↗

Analysis of TP53 gene mutations in human lung cancer: comparison of capillary electrophoresis single strand conformation polymorphism assay with denaturing gradient gel electrophoresis and direct sequencing.Semantic proximity Read ↗

Validation of fluorescent SSCP analysis for sensitive detection of p53 mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.